Funding, News and Announcements

This program seeks projects that will address quality gaps in headache medicine, with a goal of producing information or tools that can be widely used in the field and lead to measurable improvements in healthcare services for individuals with headache. Projects should also contribute to the core goal of the American Headache Society (AHS) – improving the lives of people impacted by migraine and other headache disorders.

Projects should focus on safety, clinical effectiveness, rapidity of diagnosis/proper treatment, efficiency, patient-centered care, and/or equity.

The program is not intended to support laboratory science or clinical trials.

Individual projects requesting up to $375,000 total over two (2) years will be considered. Proposals with smaller budgets are also encouraged.

Click here for more details [PDF].

Contact Details

Internal: ird@dal.ca
External: Angelo Carter (Angelo.Carter@pfizer.com), with the subject line “Headache and Migraine Grant Program –2024”

Deadlines

Internal: LOIs due by July 22, 2024
External:  LOIs due August 5, 2024

The grants facilitator for your faculty can be found on the staff contact page. For additional resources, click here for guidance on internal deadlines and submission processes.